29th Annual Meeting of the American Society of Photobiology

Downtown Marriot

Chicago, Il.

July 7th-12th, 2001


Recommended Exposure Schedules for Sunlamps and Tanning Beds: Past, Present and Future.

Cyr, W. Howard1.
U.S. Food and Drug Administration, Center for Devices and Radiological Health1

Abstract-
The U.S. Food and Drug Administration (FDA) requires manufacturers of sunlamps and tanning beds to provide "a recommended exposure schedule including the duration and spacing of sequential exposures and maximum exposure time(s) in minutes" [21 CFR 1040.20(d)(1)(iv)]. A recommended exposure schedule was described in a 1986 FDA Policy Letter and was developed in order to "allow a person to gradually build-up skin pigmentation and to maintain a tan while controlling the risk of acute injury and delayed adverse effects". FDA has recently announced its intention to amend the existing regulations on sunlamps and tanning beds to account for scientific advances since 1986, and to attempt to achieve international harmonization of its standards. Several changes have been discussed including the addition of a possible annual UV dose limit based on the risk of skin cancer (UV doses weighted with a cancer action spectrum), in a manner similar to that of the International Electrotechnical Commission (IEC). In addition, the value for minimal erythema dose (MED) may be changed from the 1986 value of 156 J/m2 to a value that is more consistent with research data (200 J/m2). Also, the time between consecutive tanning sessions has been debated. Recent studies indicate that the FDA recommended exposure schedule does not lead to skin burns, but does require several tanning sessions before pigmentation develops. In addition, a more recent study indicates that an UV-induced tan may last for several weeks, if not months. Ongoing research on methods to measure skin pigmentation could lead to better prediction of UV sensitivity and improved exposure schedules for different skin types. FDA continues to work with the indoor tanning industry, the medical community, academia and others in considering possible changes to its existing regulations.

Keywords: ultraviolet, sunlamp, regulation, dose